
Oncology
Daraxonrasib: Shifting the Paradigm in Metastatic Pancreatic Cancer
For decades, clinicians treating metastatic pancreatic ductal adenocarcinoma (mPDAC) have operated under a somber reality.
Rayan Salih · June 2, 2026 · 8 min
Stories from people navigating Pancreatic Cancer — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories

Oncology
For decades, clinicians treating metastatic pancreatic ductal adenocarcinoma (mPDAC) have operated under a somber reality.
Rayan Salih · June 2, 2026 · 8 min

Oncology
Setidegrasib is a new experimental drug that has been formulated to target a mutant version of the KRAS
Dr. Abu Bakar · 7 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.